Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Adolor gains on Pfizer deal

ADLR gained $0.73 (19%) to $4.48 on Wednesday after it entered into an

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE